HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis

Abdel-Fatah, TMA, McArdle, SE ORCID: https://orcid.org/0000-0001-6929-9782, Agarwal, D, Moseley, PM, Green, AR, Ball, GR ORCID: https://orcid.org/0000-0001-5828-7129, Pockley, AG ORCID: https://orcid.org/0000-0001-9593-6431, Ellis, IO, Rees, RC ORCID: https://orcid.org/0000-0002-4574-4746 and Chan, SYT, 2016. HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research, 22 (4), pp. 905-914. ISSN 1078-0432

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Clinical Cancer Research
Creators:	Abdel-Fatah, T.M.A., McArdle, S.E., Agarwal, D., Moseley, P.M., Green, A.R., Ball, G.R., Pockley, A.G., Ellis, I.O., Rees, R.C. and Chan, S.Y.T.
Publisher:	American Association for Cancer Research
Place of Publication:	Philadelphia, PA, USA
Date:	February 2016
Volume:	22
Number:	4
ISSN:	1078-0432
Identifiers:	Number Type 10.1158/1078-0432.CCR-15-0610 DOI 405930 Other
Divisions:	Schools > School of Science and Technology
Record created by:	EPrints Services
Date Added:	09 Oct 2015 09:47
Last Modified:	11 Oct 2021 13:24
URI:	https://irep.ntu.ac.uk/id/eprint/2754

Actions (login required)

Edit View

Statistics

Views

Downloads